Stock Yearly Return 2017
Start date: 01/03/2017
End date: 12/29/2017
Start price/share: $3,112.50
End price/share: $577.50
Dividends collected/share: $0.00
Total return: -81.45%
NVIV Average Annual Return: -82.58%
Starting investment: $10,000.00
Ending investment: $1,855.00
Years: 0.99


NVIV average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare NVIV average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into NVIV


Also see:
NVIV stock yearly return 2018
NVIV stock yearly return 2019
NVIV stock yearly return 2020
NVIV YTD return
NVIV average annual return 10 years
InVivo Therapeutics Holdings is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. Co.'s Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The Neuro-Spinal Scaffold implant is intended to provide support to the surrounding tissue after injury, minimize expansion of areas of necrosis, and provide a biomaterial substrate for the body's own healing/repair processes following injury. The Neuro-Spinal Scaffold is composed of poly lactic-co-glycolic acid and Poly-L-Lysine biocompatible and bioresorbable polymers. The NVIV stock yearly return is shown above.

The yearly return on the NVIV stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2017 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the NVIV annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for NVIV:
NVIV SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
InVivo Therapeutics Holdings (NVIV) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

NVO Average Annual Return
NVRO Average Annual Return
NVTA Average Annual Return
NVTR Average Annual Return
NVUS Average Annual Return
NXTM Average Annual Return
NYMX Average Annual Return
OBLN Average Annual Return
OCUL Average Annual Return
OCX Average Annual Return
More Healthcare companies »

 

NVIV Stock Yearly Return 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.